TCR2 Therapeutics Revenue, Growth & Competitor Profile

DBA TCR2, INC.

Company Profile & Annual Report for TCR2 Therapeutics

Access the complete profile.

TCR2 Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	100 Binney Street, Suite 710 Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


TCR2 Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • TCR2 Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • TCR2 Therapeutics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

TCR2 Therapeutics Annual Revenue and Growth Rate

TCR2 Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: TCR2 Therapeutics's revenues are gauged from an analysis of company filings.

TCR2 Therapeutics's Income Statement (based on Industry Averages)

TCR2 Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that TCR2 Therapeutics is developing and marketing. TCR2 Therapeutics doesn't have any recent trademark applications, indicating TCR2 Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TCR2 THERAPEUTICS Pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases	10/28/2021
TCR² THERAPEUTICS Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases	10/30/2018

See all trademarks and details in the Full Report.

Market Share of TCR2 Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as TCR2 Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to TCR2 Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MODERNATX	Cambridge, MA	100
CENTOGENE US	Cambridge, MA	7
THRIVE EARLIER DETECTION	Cambridge, MA	5
TCR2 THERAPEUTICS	Cambridge, MA	2
SHERLOCK BIOSCIENCES	Brighton, MA	2
ABACUS INSIGHTS	Boston, MA	2

Future Competition: TCR2 Therapeutics's Fastest Growing Competitors

These companies are in the same general field as TCR2 Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)